BMRA: Biomerica Inc. Company Profile & Statistics

About

BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.

Info & Links

CEO

Zackary S. Irani

Headquarters

17571 Von Karman Avenue
Irvine, CA 92614, UNITED STATES

Auditor

HASKELL & WHITE LLP

Share holders

850

Employees

Biomerica Inc. Statistics

Valuation Measures

Market Capitalization²

10.61M

Enterprise Value

8.23M

Enterprise Value/EBITDA(ttm)

-1.50

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.97

Price to Book(mrq)

1.97

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

7.53%

Operating Margin(ttm)

-100.52%

Profit Margin(ttm)

-111.65%

Return on Equity(ttm)

-90.19%

Return on Invested Capital(ttm)

-89.32%

Return on Assets(ttm)

-64.54%

Income Statement

Revenue(ttm)

5.58M

Revenue Per Share(ttm)

0.30

Gross Profit(ttm)

600.00K

EBITDA(ttm)³

-5.50M

Net Income Available to Common(ttm)

-5.61M

Diluted EPS(ttm)

-0.34

Share Statistics

Beta (5Y Monthly)

-1.04

52-Week Change

-32.93%

S&P 500 52-Week Change

25.40%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

18.34M

Dividend Yield

0.00%

Float⁴

15.59M

% Held by Insiders

15.00%

% Held by Institutions

22.28%

Balance Sheet

Total Cash(mrq)

2.37M

Total Cash Per Share(mrq)

0.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.17%

Quick Ratio(mrq)

2.22%

Book Value Per Share(mrq)

0.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.12

Free Cash Flow(ytd)

-2.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BMRA

Biomerica Inc.

Biomerica Inc. Profile